As of 2024-12-14, the Relative Valuation of Greenwich Lifesciences Inc (GLSI) is (18.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.21 USD, the upside of Greenwich Lifesciences Inc based on Relative Valuation is -237.1%.
The range of the Relative Valuation is (16.74) - (15.53) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.0x - 31.3x | 26.2x |
| Forward P/E multiples | 19.0x - 19.4x | 19.2x |
| Fair Price | (16.74) - (15.53) | (18.11) |
| Upside | -226.7% - -217.5% | -237.1% |
| Date | P/E |
| 2024-12-06 | -17.10 |
| 2024-12-05 | -16.88 |
| 2024-12-04 | -17.34 |
| 2024-12-03 | -17.64 |
| 2024-12-02 | -18.72 |
| 2024-11-29 | -17.84 |
| 2024-11-27 | -18.24 |
| 2024-11-26 | -17.97 |
| 2024-11-25 | -17.45 |
| 2024-11-22 | -16.96 |
| 2024-11-21 | -16.24 |
| 2024-11-20 | -16.09 |
| 2024-11-19 | -15.99 |
| 2024-11-18 | -15.49 |
| 2024-11-15 | -15.72 |
| 2024-11-14 | -17.01 |
| 2024-11-13 | -16.71 |
| 2024-11-12 | -16.99 |
| 2024-11-11 | -17.60 |
| 2024-11-08 | -18.02 |
| 2024-11-07 | -17.29 |
| 2024-11-06 | -18.05 |
| 2024-11-05 | -17.10 |
| 2024-11-04 | -16.39 |
| 2024-11-01 | -16.83 |
| 2024-10-31 | -16.84 |
| 2024-10-30 | -18.02 |
| 2024-10-29 | -17.72 |
| 2024-10-28 | -17.44 |
| 2024-10-25 | -16.90 |
| 2024-10-24 | -17.01 |
| 2024-10-23 | -17.01 |
| 2024-10-22 | -17.28 |
| 2024-10-21 | -16.76 |
| 2024-10-18 | -16.94 |
| 2024-10-17 | -17.78 |
| 2024-10-16 | -17.50 |
| 2024-10-15 | -17.73 |
| 2024-10-14 | -17.26 |
| 2024-10-11 | -17.19 |
| 2024-10-10 | -16.15 |
| 2024-10-09 | -16.21 |
| 2024-10-08 | -16.96 |
| 2024-10-07 | -17.05 |
| 2024-10-04 | -17.20 |
| 2024-10-03 | -17.10 |
| 2024-10-02 | -17.49 |
| 2024-10-01 | -17.35 |
| 2024-09-30 | -17.99 |
| 2024-09-27 | -17.72 |